Now enrolling in Brooksville

Cirrhosis from fatty liver? A research study is enrolling in Brooksville.

For adults with compensated cirrhosis linked to fatty liver disease (MASH or NASH) — including people who are overweight or have type 2 diabetes, high blood pressure, or high cholesterol. The study is testing an investigational once-weekly study medication.

  • Study medication and study-related care at no cost
  • No insurance needed
  • Compensation provided for your time
  • Transportation available at no cost
See if you may qualify: 4 quick questions

11373 Cortez Blvd, Brooksville · next to Oak Hill Hospital

Step 1 of 2

See if you may qualify

1 / 2

Question 1 of 4

What has a doctor told you about your liver?

Liver diagnosis

Question 2 of 4

Have you ever had any of these liver problems? Select all that apply.

Past liver complications

Question 3 of 4

Do any of these apply to you? Select all that apply.

Other health conditions

Question 4 of 4

Can you get to our office in Brooksville (next to Oak Hill Hospital) for study visits? Transportation can be arranged at no cost.

Getting to the Brooksville office

Not sure about something? Pick the closest answer — the coordinator will check the details with you.

Here’s exactly who we’re looking for

This study may be for you if…

You don't need your records handy. An ARI coordinator can review what you already know and check the details with you.

  • Age 18 or older and able to get to Brooksville. Transportation can be arranged at no cost.
  • Told by a doctor you have cirrhosis linked to fatty liver (MASH / NASH), or cirrhosis without a clear cause.
  • Your cirrhosis has never caused fluid build-up in the belly, liver-related confusion, or bleeding from swollen veins.
  • Overweight, or living with type 2 diabetes, high blood pressure, or high cholesterol.

Told you have liver scarring, but not cirrhosis? ARI has a related study for earlier-stage scarring. Answer the questions anyway — the coordinator will check which study may fit.

What participants get

What taking part includes.

The study is testing whether an investigational once-weekly injection may help people with compensated MASH cirrhosis. It is given in addition to your usual medicines. There is no guarantee it will help, and taking part is always your choice.

Liver check-ups

Study-related visits, lab work, and liver scans such as FibroScan are provided at no cost.

Study medication

The investigational study medication or placebo is provided at no cost. No insurance is needed.

A team that stays in touch

A dedicated study team at Access Research Institute guides you through each visit and answers your questions.

Help getting to visits

Transportation to and from study visits can be arranged at no cost if you need it.

Compensation provided for your time. The coordinator can explain the details.

How it works

A quick check. Then you decide.

  1. 01

    Answer 4 questions

    Tell us about your liver. It takes about a minute.

  2. 02

    A coordinator calls

    ARI reviews your answers and talks through the study with you.

  3. 03

    Screening in Brooksville

    If the study may fit, the next step is a no-cost screening visit at our Brooksville office.

  4. 04

    You decide

    Review the details, ask questions, and decide whether you want to join.

Common questions

Know before you decide.

Short answers about cost, placebo, the study medication, visits, and what comes next.

Call (352) 691-1140
  • Is there a cost? Do I need insurance?

    No. Study-related visits, tests, and study medication are provided at no cost, and you do not need insurance to take part. Compensation provided for your time.

  • What does "compensated" cirrhosis mean?

    It means the liver is scarred but still doing its main jobs, and you have never had complications such as fluid build-up in the belly, liver-related confusion, or bleeding from swollen veins. If you're not sure, the coordinator can help.

  • Do I have to join after I answer the questions?

    No. Answering the questions only lets Access Research Institute know you may be interested. You can ask questions and decide later, and you can leave the study at any time. Your information is handled under our privacy policy.

  • Will I get a placebo?

    Possibly. About 2 out of every 3 participants receive the investigational study medication and about 1 out of 3 receive a placebo (an injection with no active medicine). Neither you nor the study team chooses which.

  • How is the study medication given?

    As a small injection under the skin once a week, in addition to your usual medicines. The study team will show you how it works.

  • Can I keep taking my current medicines?

    Usually, yes — the study medication is added to your usual care. Some medicines may not be allowed. Don't change anything on your own; the study doctor will go over your list with you.

  • What does screening involve?

    Screening usually includes a check-up, blood tests, and a liver scan such as FibroScan. The team reviews any past biopsy or scan results too, and explains every step before you decide.

  • How long does the study last?

    This is a long-term study, expected to run about 4 to 5 years, though it may end sooner or later. You can stop at any time.

  • Told you have liver scarring but not cirrhosis?

    ARI also has a study for earlier-stage scarring. Answer the questions and the coordinator will check which study may fit.

Visit us in Brooksville.

Access Research Institute is on Cortez Blvd, next to Oak Hill Hospital. Transportation to and from study visits can be arranged at no cost.

  • Access Research Institute11373 Cortez Blvd, Building C, Suite 200Brooksville, FL 34613Next to Oak Hill Hospital
  • HoursCall for current appointment hours
  • Phone(352) 691-1140
  • Getting hereTransportation available at no cost if you need it

Four quick questions

See if the cirrhosis study may fit.

No commitment. An ARI coordinator will explain the details and answer your questions before you decide.

See if you may qualify